OcuSense Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
Corporate
- Financing Rounds
-
3
OcuSense General Information
Description
Manufacturer of diagnostic pharmaceutical products. The company operates as an ophthalmic device company commercializing novel, laboratory-on-a-card technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears.
Contact Information
Primary Industry
Diagnostic Equipment
Acquirer
Primary Office
- 12707 High Bluff Drive
- Suite 200
- San Diego, CA 92130
- United States
OcuSense Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
OcuSense Patents
OcuSense Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1745271-A2 | Systems and methods for reducing the effect of corruptive signals during nanoliter osmometry | Inactive | 25-Mar-2004 | 000000000 | |
| EP-1745271-A4 | Systems and methods for reducing the effect of corruptive signals during nanoliter osmometry | Inactive | 25-Mar-2004 | 000000000 | 0 |
| JP-2007530953-A | System and method for reducing the effects of fraudulent signals during nanoliter osmolarity measurement | Active | 25-Mar-2004 | 000000000 | |
| JP-4874951-B2 | System and method for reducing the effects of fraudulent signals during nanoliter osmolarity measurement | Inactive | 25-Mar-2004 | 000000000 | |
| US-20050201895-A1 | Osmolarity measuring system; an aliquot of sample fluid, such as human tear film, is collected with a capillary tube; receiving device coupled to mechanical translation system captures the capillary tube; coarse and fine adjustment | Inactive | 12-Mar-2004 | G01N13/04 |